Rachel E. Johns

Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs

B. Polisky, Brian Granger, M. Templin, 2010, Nucleic acids research.

Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic

R. Maier, A. Hoffman, J. Cuschieri, 2008, Journal of biomaterials science. Polymer edition.

RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.

B. Polisky, M. Templin, P. Harvie, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.

B. Polisky, M. Templin, P. Harvie, 2011, Molecular Therapy.

Differential monocyte/macrophage interleukin-1β production due to biomaterial topography requires the β2 integrin signaling pathway.

R. Maier, P. Stayton, Rachel E. Johns, 2011, Journal of biomedical materials research. Part A.

Disposition and Oral Bioavailability in Rats of an Antiviral and Antitumor Amino Acid Phosphoramidate Prodrug of AZT-Monophosphate

C. Wagner, Rachel E. Johns, C. Zimmerman, 2003, Pharmaceutical Research.

Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects.

M. Templin, S. Seth, Rachel E. Johns, 2012, Therapeutic delivery.

Electricity-Free Amplification and Detection for Molecular Point-of-Care Diagnosis of HIV-1

Will Price, Dylan Guelig, Kelly B. Ebels, 2014, PloS one.

Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)

Barbora Malecova, B. Darimont, A. Levin, 2023, Nucleic acids research.